[MUSIC PLAYING] Chemotherapy is a very broad term used to describe agents that go into the veins through an IV to treat prostate cancer that has spread to other parts of the body. These medicines ...

The Olympic champion who is battling terminal prostate cancer said he is acutely aware the illness will not disappear all of a sudden. But post chemotherapy he has been able to work on his ...

chemotherapy-induced menopause) or hormonal treatments, such as tamoxifen or aromatase inhibitors for breast cancer or androgen ablation for prostate cancer. The effects of chemotherapy-associated ...

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming ... during or after docetaxel-based chemotherapy. Two agents (cabazitaxel and ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on ...

Lenny Santoro credits NIH research with saving his life longer than doctors expected. Duke Health's Dr. Daniel George warns ...

More debate about whether the lowest-risk prostate cancers should ... KRAS G12C-mutated metastatic colorectal cancer after specific chemotherapy regimens. The agency also approved acalabrutinib ...

in mCRPC patients previously treated with hormonal therapy and chemo. Merck’s run of bad results is unfortunately par for the course for checkpoint inhibitors in prostate cancer, with other ...

The Food and Drug Administration (FDA) has expanded the approval of Pluvicto ® (lutetium Lu 177 vipivotide tetraxetan) to include patients with prostate ... to delay chemotherapy, in addition ...

Nauseef JT, Sun MP, Thomas C, et al. A phase I/II dose-escalation study of fractionated 225Ac-J591 for progressive metastatic castration-resistant prostate cancer in patients with prior treatment with ...

The University of Queensland will play a key role in a national effort to revolutionize treatment for men with prostate cancer.

Several randomized trials are ongoing, and it is anticipated that the results of these studies will help to identify whether the early use of chemotherapy in early prostate cancer is beneficial.